English
Home > Products > 120068-37-3

China 120068-37-3 Factory

To become the stage of realizing dreams of our employees! To build a happier, more united and extra professional workforce! To reach a mutual advantage of our prospects, suppliers, the society and ourselves for 120068-37-3,CAS NO 120068-37-3,Fipronil API,Fipronil, We have been also the appointed OEM factory for several worlds' famous merchandise brands. Welcome to speak to us for more negotiation and cooperation.
120068-37-3, We pay high attention to customer service, and cherish every customer. We now have maintained a strong reputation in the industry for many years. We've been honest and work on building a long-term relationship with our customers.

Related Products

Hot Products

  • Indobufen

    Indobufen

    Product Name:Indobufen
    Molecular Formula:C18H17NO3
    Molecular Weight;295.34
    CAS Registry Number;63610-08-2
  • Eplerenone

    Eplerenone

    Product Name:Eplerenone
    Molecular Formula:C24H30O6
    Molecular Weight:414.49
    CAS Registry Number;107724-20-9
  • Benzyltrimethylammonium chloride

    Benzyltrimethylammonium chloride

    Product Name:Benzyltrimethylammonium chloride
    Molecular Formula:C10H16ClN
    Molecular Weight:185.69
    CAS Registry Number:56-93-9
  • Lorlatinib（PF0643922）

    Lorlatinib（PF0643922）

    Product Name:Lorlatinib（PF0643922）
    Molecular Formula:C21H19FN6O2
    Molecular Weight;406.41
    CAS Registry Number;1454846-35-5
  • Gestonoronacetat

    Gestonoronacetat

    Product Name:Gestonoronacetat
    Molecular Formula:C22H30O4
    Molecular Weight:358.47
    CAS Registry Number;31981-44-9
  • Sodium hyaluronate

    Sodium hyaluronate

    Product Name:Sodium hyaluronate
    Molecular Formula:C14H22NNaO11
    Molecular Weight:403.31
    CAS Registry Number:9067-32-7
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

Related Search

CAS NO 120068-37-3

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept